Acquisition of Biotest AG Microbiology Business Unit by Merck KGaA of Germany Approved – Important Customer Information
The acquisition of Biotest’s Microbiology division (HYCON & heipha portfolio) optimally complements Merck Millipore’s product portfolio, giving you the advantage of obtaining all your requirements from one source.
With our combined expertise and enhanced portfolio, we can now serve you even better, offering state-of-the-art microbiology testing methods as well as comprehensive regulatory knowledge and services.
The portfolio includes microbial air samplers, culture media, airborne particle counters, molecular microbiology and pyrogen test systems.
We aim to demonstrate our commitment to your needs and our dedication to providing convenient, easy-to-use and time saving solutions.
In order to facilitate the optimal integration of our products, some modifications for both the HYCON and the heipha portfolio, will be gradually implemented. These are explained on the following web pages.